Blackstone’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Blackstone's PCVX Position: Q2 2026 in Review
Blackstone sold out of Vaxcyte (PCVX) in Q2 2026, closing a stake of 4,544 shares — an estimated $264K sold.
Blackstone first reported a position in PCVX in Q1 2026 and held it in 1 quarter. The position peaked at $264K in Q1 2026. 333 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.
- Blackstone reported no remaining Vaxcyte position as of Q2 2026 after selling out during the quarter.
- Blackstone sold 4,544 Vaxcyte shares in Q2 2026, an estimated $264K.
- Blackstone first reported a position in Vaxcyte in Q1 2026 and held it in 1 quarter.
- Blackstone's Vaxcyte position peaked at $264K in Q1 2026.
- 333 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.